Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Eribulin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eribulin 1320micrograms/3ml solution for injection vials
0801050BBAAABAB
|
Eribulin | Eribulin | Malignant Disease and Immunosuppression | No data available |
|
Eribulin 880micrograms/2ml solution for injection vials
0801050BBAAAAAA
|
Eribulin | Eribulin | Malignant Disease and Immunosuppression | No data available |
|
Halaven 0.88mg/2ml solution for injection vials
0801050BBBBAAAA
|
Halaven | Eribulin | Malignant Disease and Immunosuppression | No data available |
|
Halaven 1.32mg/3ml solution for injection vials
0801050BBBBABAB
|
Halaven | Eribulin | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.